NovaBridge Biosciences (NBP) — Cash Flow Quality Index
NovaBridge Biosciences (NBP) has a Cash Flow Quality Index of -19.06x as of December 2020. Operating cash flow of $-232.84 Million is below net income of $12.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NBP long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NovaBridge Biosciences Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for NovaBridge Biosciences across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NovaBridge Biosciences (NBP) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for NovaBridge Biosciences (2020–2020)
Year-by-year earnings quality comparison for NovaBridge Biosciences. For live market cap and the full company financial profile, see market cap of NovaBridge Biosciences.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.92x | $433.56 Million | $470.92 Million | — |